NCT01030328View on ClinicalTrials.gov

AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2009

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Coronary Atherosclerosis
Interventions
DRUG

Placebo

2 sugar pills by mouth once a day.

DRUG

TriLipix

135 mg of TriLipix + 40 mg of Atorvastatin by mouth once a day

Trial Locations (1)

30309

Piedmont Hospital, Atlanta

Sponsors
All Listed Sponsors
lead

Piedmont Healthcare

OTHER